Microba Life Sciences Ltd
ASX:MAP
Relative Value
The Relative Value of one MAP stock under the Base Case scenario is hidden AUD. Compared to the current market price of 0.096 AUD, Microba Life Sciences Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MAP Competitors Multiples
Microba Life Sciences Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
M
|
Microba Life Sciences Ltd
ASX:MAP
|
51.8m AUD | 3.7 | -3.9 | -2.5 | -2.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
99.7B USD | 0.3 | 212.5 | 14 | 14 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.7B USD | 0.3 | 12.6 | 0 | 0 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.2B EUR | 0.3 | 12.5 | 8 | 10.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.8B EUR | 1.3 | 24.9 | 10.9 | 16.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
24B EUR | 1.2 | 33.3 | 10.5 | 22.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.5B USD | 1.7 | 27.4 | 14.7 | 20.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23B USD | 2.1 | 24.2 | 13 | 17.6 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 0.6 | 16.4 | 6.5 | 13.8 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.1B USD | 14.6 | -33 | -34.8 | -31.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.2B USD | 0.7 | 13.7 | 7.1 | 9.6 |